Multimedia
Featured Video
Discover NIMH: Drug Discovery and Development
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
Health Topics
-
Director’s Innovation Speaker Series: HIV-1 and SARS-CoV-2 Effects on Brain and Mind Health: A Tale of Two Viruses
-
Center for Global Mental Health Research Webinar Series: Writing a Successful Individual Training Grant Application Focused on Global Mental Health
-
Facebook Live: The Intersection of Suicide and Substance Use
-
Office for Disparities Research and Workforce Diversity Webinar Series: Advancing Methods and Measures to Examine the Underlying Mechanisms of Violent Deaths in LGBTQ Populations
Populations
-
Director’s Innovation Speaker Series: Transformative Research Requires Insider Researchers
-
Center for Global Mental Health Research Webinar Series: Grants Management: Post Award
-
Center for Global Mental Health Research Webinar Series: Writing a Successful Individual Training Grant Application Focused on Global Mental Health
-
Center for Global Mental Health Research Webinar Series: Establishing an Independent Career in Global Mental Health Research
Research
-
Director’s Innovation Speaker Series: Transformative Research Requires Insider Researchers
-
Center for Global Mental Health Research Webinar Series: Grants Management: Post Award
-
Director’s Innovation Speaker Series: All of Us Research Program: Improving Health Through Innovative Technology, Large and Diverse Cohorts, and Precision Medicine
-
Dr. Ruth Shim – Achieving Equity in Mental Health Services Research (Mental Health Services Research Conference Day 2 Keynote Address)